ロード中...
Successful Rechallenge with Osimertinib after Very Acute Onset of Drug-Induced Pneumonitis
Drug-induced interstitial lung disease (DI-ILD) is a rare, yet life-threatening complication associated with tyrosine-kinase inhibitor (TKI) therapy. Third-generation epidermal growth factor receptor-TKI, osimertinib use can be associated with a benign radiological finding called transient asymptoma...
保存先:
| 出版年: | Case Rep Oncol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
S. Karger AG
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8216030/ https://ncbi.nlm.nih.gov/pubmed/34177523 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000516274 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|